Comparison Between Stair Climbing and One Mile Walking in Relation to Cardiorespiratory Fitness

December 30, 2015 updated by: Imtiyaz Ali Mir, Universiti Tunku Abdul Rahman
The worldwide epidemic of physical inactivity is rising significantly and the main cause is sedentary lifestyle. In this era of globalization and rapid advancement of technology, people are chasing after worldly matters, leading them to abandon the most important factor in their life and that's their body. Most people are leading a sedentary lifestyle as they indulge themselves in their never-ending work. There is a significant lack of awareness on the importance of physical activity and cardiorespiratory fitness to health as people are focusing more on factors such as smoking, cholesterol and hypertension. The purpose of this study is to evaluate the effectiveness of stair climbing (SC) and 1 mile walking (1MW) in relation to cardiorespiratory responses and fitness.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The incidences of chronic diseases and cardiovascular diseases are escalating rapidly and fingers are being pointed to physical inactivity and poor cardiorespiratory fitness as one of the few main 'predictors of premature mortality. According to WHO (2015), 23% of adults above the age of 18 years old were insufficiently physically active in 2010, with men scoring 20% and women 27%. Comparing high income and low income countries, 26% of men and 35% of women of high income countries was said to be insufficiently physically active compared to 12% of men and 24% of women of low income countries. This may be due to the fact that people of high income countries are more engrossed in chasing after worldly matters at work and preferring a sedentary lifestyle at home after work. Globally, adolescents between the age of 11 to 17 years old scored a high percentage of 81% of being insufficiently physically active and this may be because adolescents prefer to spend more time on internet, playing games on computers or watching dramas or movies. In the Physical Activity Statistics 2015 by the British Heart Foundation, it is reported that North West of England has the highest level of physical inactivity with 26% for men and 31% for female. It was also mentioned that household incomes play a role in the level of physical activity in England. In 2012, 29% men and 34% women from the lowest quintile of household income in England were physically inactive compared to 11% men and 18% women of the highest quintile of household income.[1] In Malaysia a research conducted on physical activity index among Malaysian youth and out of 1801 respondents, 23% men and 31.3% women were insufficiently physically active.[2] In another research on the Prevalence and Factors Associated with Physical Inactivity among Malaysian Adults, the overall prevalence of physical inactivity was 43.7%.[3] Similar to other researchers, results also show that women are more physically inactive at 9 465 (50.5%) out of 18 744 female respondents compared to men at 5367 (35.3%) out of 15205 male respondents. It is important to ensure that everyone participates in physical activities in effort to improve their health and indirectly reduce the risk of mortality. Hence, the researcher aims to compare the effects of stair climbing and one mile walking in relation to cardiorespiratory responses and fitness to find which one is better compared to other as these type of activates can be performed in any settings and does not require sophisticated equipments.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
34

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Phase 1

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 25 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Sedentary Adults
  • Height:160cm to 170cm
  • Willing to participate

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: 1 mile Walk using treadmill
Walking for 1 mile on treadmill (American Motion Fitness, 8800D) as fast as participant can, without any inclination
Device: 1 mile walk using treadmill
Walk for 1 mile on treadmill (American Motion Fitness, 8800D) at self selected speed as fast as participant can without any inclination.
Experimental: Stair Climbing
30 meters of vertical distance to be covered (14 flights of stairs with a total of 154 steps)
Device: Stair Climbing
Climb 14 flights of stairs at self selected speed. No double step at a time and running allowed.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Physical Fitness Index
Time Frame: At baseline and at end of 4 weeks of intervention
''Change'' is being assessed
At baseline and at end of 4 weeks of intervention
V02max
Time Frame: At baseline and at end of 4 weeks of intervention
''Change'' is being assessed
At baseline and at end of 4 weeks of intervention

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Recovery Heart Rate
Time Frame: At baseline and at end of 4 weeks of intervention
''Change'' is being assessed
At baseline and at end of 4 weeks of intervention
Systolic & Diastolic Blood Pressure
Time Frame: At baseline and at end of 4 weeks of intervention
''Change'' is being assessed
At baseline and at end of 4 weeks of intervention
Respiratory Rate
Time Frame: At baseline and at end of 4 weeks of intervention
''Change'' is being assessed
At baseline and at end of 4 weeks of intervention
Rate of Perceived Exertion
Time Frame: At baseline and at end of 4 weeks of intervention
''Change'' is being assessed
At baseline and at end of 4 weeks of intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Universiti Tunku Abdul Rahman

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
October 1, 2015

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
November 1, 2015

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 1, 2015

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
December 28, 2015

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 30, 2015

First Posted (Estimate)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 1, 2016

Study Record Updates

Last Update Posted (Estimate)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 1, 2016

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 30, 2015

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
December 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • U/SERC/83/2015

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

It is confidential

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings